{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:19Z","timestamp":1786982179272,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12013-021-00974-1","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T09:03:33Z","timestamp":1615367013000},"page":"349-357","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Suberoylanilide Hydroxamic Acid (SAHA) Reduces Fibrosis Markers and Deactivates Human Stellate Cells via the Epithelial\u2013Mesenchymal Transition (EMT)"],"prefix":"10.1007","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0434-9731","authenticated-orcid":false,"given":"Merve","family":"\u00d6zel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mevlut","family":"Baskol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilal","family":"Akal\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulden","family":"Baskol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"key":"974_CR1","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.3748\/wjg.v20.i23.7260","volume":"20","author":"G\u00d6 Elpek","year":"2014","unstructured":"Elpek, G. \u00d6. (2014). Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: an update. World Journal of Gastroenterology, 20, 7260\u20137276.","journal-title":"World Journal of Gastroenterology"},{"key":"974_CR2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","volume":"121","author":"T Higashi","year":"2017","unstructured":"Higashi, T., Friedman, S. L., & Hoshida, Y. (2017). Hepatic stellate cells as key target in liver fibrosis. Advanced Drug Delivery Reviews, 121, 27\u201342.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"974_CR3","doi-asserted-by":"crossref","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","volume":"22","author":"CY Zhang","year":"2016","unstructured":"Zhang, C. Y., Yuan, W. G., He, P., Lei, J. H., & Wang, C. X. (2016). Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets. World Journal of Gastroenterology, 22, 10512\u201310522.","journal-title":"World Journal of Gastroenterology"},{"key":"974_CR4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida, T., & Friedman, S. L. (2017). Mechanisms of hepatic stellate cell activation. Nature Reviews Gastroenterology & Hepatology, 14, 397\u2013411.","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"974_CR5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/abbs\/gmv116","volume":"48","author":"B Ning","year":"2016","unstructured":"Ning, B., Li, W., Zhao, W., & Wang, R. (2016). Targeting epigenetic regulations in cancer. Acta Biochimica et Biophysica Sinica, 48, 97\u2013109.","journal-title":"Acta Biochimica et Biophysica Sinica"},{"key":"974_CR6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4103\/0973-1482.137937","volume":"10","author":"KC Lakshmaiah","year":"2014","unstructured":"Lakshmaiah, K. C., Jacob, L. A., Aparna, S., Lokanatha, D., & Saldanha, S. C. (2014). Epigenetic therapy of cancer with histone deacetylase inhibitors. Journal of Cancer Researche and Therapeutics, 10, 469\u2013478.","journal-title":"Journal of Cancer Researche and Therapeutics"},{"key":"974_CR7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejmech.2016.05.047","volume":"121","author":"J Roche","year":"2016","unstructured":"Roche, J., & Bertrand, P. (2016). Inside HDACs with more selective HDAC inhibitors. European Journal of Medicinal Chemistry, 121, 451\u2013483.","journal-title":"European Journal of Medicinal Chemistry"},{"key":"974_CR8","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.2174\/0929867324666170223153115","volume":"24","author":"A Richters","year":"2017","unstructured":"Richters, A., & Koehler, A. N. (2017). Epigenetic modulation using small molecules\u2014-targeting histone acetyltransferases in disease. Current Medicinal Chemistry, 24, 4121\u20134150.","journal-title":"Current Medicinal Chemistry"},{"key":"974_CR9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1055\/s-0037-1605371","volume":"37","author":"V Massey","year":"2017","unstructured":"Massey, V., Cabezas, J., & Bataller, R. (2017). Epigenetics in liver fibrosis. Seminars in Liver Disease, 37, 219\u2013230.","journal-title":"Seminars in Liver Disease"},{"key":"974_CR10","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.3390\/ijms19092630","volume":"19","author":"MJ Hadden","year":"2018","unstructured":"Hadden, M. J., & Advani, A. (2018). Histone deacetylase inhibitors and diabetic kidney disease. International Journal of Molecular Science, 19, 2630.","journal-title":"International Journal of Molecular Science"},{"key":"974_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1755-1536-6-1","volume":"6","author":"KV Beneden","year":"2013","unstructured":"Beneden, K. V., Mannaerts, I., Pauwels, M., Branden, C. V., & van Grunsven, L. A. (2013). HDAC inhibitors in experimental liver and kidney fibrosis. Fibrogenesis & Tissue Repair, 6, 1.","journal-title":"Fibrogenesis & Tissue Repair"},{"key":"974_CR12","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/AAC.01220-10","volume":"55","author":"J Marfurt","year":"2011","unstructured":"Marfurt, J., Chalfein, F., Prayoga, P., Wabiser, F., Kenangalem, E., & Piera, K. A., et al. (2011). Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivax. Antimicrobial Agents and Chemotherapy, 55, 961\u2013966.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"974_CR13","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.3390\/cells9102321","volume":"9","author":"A Claveria-Cabello","year":"2020","unstructured":"Claveria-Cabello, A., Colyn, L., Arechederra, M., Urman, J. M., Berasain, C., & Avila, M. A., et al. (2020). Epigenetics in liver fibrosis: could HDACs be a therapeutic target? Cells, 9, 2321.","journal-title":"Cells"},{"key":"974_CR14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4254\/wjh.v6.i4.207","volume":"6","author":"SJ Lee","year":"2014","unstructured":"Lee, S. J., Kim, K. H., & Park, K. K. (2014). Mechanisms of fibrogenesis in liver cirrhosis: the molecular aspects of epithelial-mesenchymal transition. World Journal of Hepatology, 6, 207\u2013216.","journal-title":"World Journal of Hepatology"},{"key":"974_CR15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1387\/ijdb.041793ld","volume":"48","author":"LD Derycke","year":"2004","unstructured":"Derycke, L. D., & Bracke, M. E. (2004). N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. The International Journal of Developmental Biology, 48, 463\u2013476.","journal-title":"The International Journal of Developmental Biology"},{"key":"974_CR16","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1242\/jcs.113.13.2455","volume":"113","author":"B Eckes","year":"2000","unstructured":"Eckes, B., Colucci-Guyon, E., Smola, H., Nodder, S., Babinet, C., & Krieg, T., et al. (2000). Impaired wound healing in embryonic and adult mice lacking vimentin. Journal of Cell Science, 113, 2455\u20132462.","journal-title":"Journal of Cell Science"},{"key":"974_CR17","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri, R., & Weinberg, R. A. (2009). The basics of epithelial-mesenchymal transition. Journal of Clinical Investigation, 119, 1420\u20131428.","journal-title":"Journal of Clinical Investigation"},{"key":"974_CR18","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1083\/jcb.200601018","volume":"172","author":"JM Lee","year":"2006","unstructured":"Lee, J. M., Dedhar\u00fc, S., Kalluri, R., & Thompson, E. W. (2006). The epithelial-mesenchymal transition: new insights in signaling, development, and disease. Journal of Cell Biology, 172, 973\u2013981.","journal-title":"Journal of Cell Biology"},{"key":"974_CR19","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI200320530","volume":"112","author":"R Kalluri","year":"2003","unstructured":"Kalluri, R., & Neilson, E. G. (2003). Epithelial-mesenchymal transition and its implications for fibrosis. Journal of Clinical Investigation, 112, 1776\u20131784.","journal-title":"Journal of Clinical Investigation"},{"key":"974_CR20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2741\/S368","volume":"5","author":"P Kocabayoglu","year":"2013","unstructured":"Kocabayoglu, P., & Friedman, S. L. (2013). Cellular basis of hepatic fibrosis and its role in inflammation and cancer. Frontier Bioscience, 5, 217\u2013230.","journal-title":"Frontier Bioscience"},{"key":"974_CR21","doi-asserted-by":"crossref","first-page":"75692","DOI":"10.1371\/journal.pone.0075692","volume":"8","author":"R Weiskirchen","year":"2013","unstructured":"Weiskirchen, R., Weimer, J., Meurer, S. K., Kron, A., Seipel, B., & Vater, I., et al. (2013). Genetic characteristics of the human hepatic stellate cell line LX-2. PLoS ONE, 8, 75692.","journal-title":"PLoS ONE"},{"key":"974_CR22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.humpath.2007.05.021","volume":"39","author":"R D\u00edaz","year":"2008","unstructured":"D\u00edaz, R., Kim, J. W., Hui, J. J., Li, Z., Swain, G. P., & Fong, K. S., et al. (2008). Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis. Human Pathology, 39, 102\u2013115.","journal-title":"Human Pathology"},{"key":"974_CR23","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1053\/j.gastro.2009.06.051","volume":"137","author":"WK Syn","year":"2009","unstructured":"Syn, W. K., Jung, Y., Omenetti, A., Abdelmalek, M., Guy, C. D., & Yang, L., et al. (2009). Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease. Gastroenterology, 137, 1478\u20131488.","journal-title":"Gastroenterology"},{"key":"974_CR24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.addr.2017.10.011","volume":"121","author":"CL Wilson","year":"2017","unstructured":"Wilson, C. L., Mann, D. A., & Borthwick, L. A. (2017). Epigenetic reprogramming in liver fibrosis and cancer. Advanced Drug Delivery Reviews, 121, 124\u2013132.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"974_CR25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/1574892810666150317144511","volume":"10","author":"C De Souza","year":"2015","unstructured":"De Souza, C., & Chatterji, B. P. (2015). HDAC inhibitors as novel anti-cancer therapeutics. Recent Patients on Anticancer Drug Discovery, 10, 145\u2013162.","journal-title":"Recent Patients on Anticancer Drug Discovery"},{"key":"974_CR26","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.3748\/wjg.v19.i31.5159","volume":"19","author":"YC Wang","year":"2013","unstructured":"Wang, Y. C., Yang, X., Xing, L. H., & Kong, W. Z. (2013). Effects of SAHA on proliferation and apoptosis of hepatocellular carcinoma cells and hepatitis B virus replication. World Jounal of Gastroenterology, 19, 5159\u20135164.","journal-title":"World Jounal of Gastroenterology"},{"key":"974_CR27","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2014.17","volume":"3","author":"S Hibino","year":"2014","unstructured":"Hibino, S., Saito, Y., Muramatsu, T., Otani, A., Kasai, Y., & Kimura, M., et al. (2014). Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells. Oncogenesis, 3, e104 doi: 10.1038\/oncsis.","journal-title":"Oncogenesis"},{"key":"974_CR28","doi-asserted-by":"crossref","first-page":"56508","DOI":"10.18632\/oncotarget.10643","volume":"7","author":"H Lu","year":"2016","unstructured":"Lu, H., Yang, X. F., Tian, X. Q., Tang, S. L., Li, L. Q., & Zhao, S., et al. (2016). The in vitro and vivo anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) and MG132 on the aggressive phenotypes of gastric cancer cells. Oncotarget, 7, 56508\u201356525.","journal-title":"Oncotarget"},{"key":"974_CR29","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s10495-016-1278-6","volume":"21","author":"C Srinivas","year":"2016","unstructured":"Srinivas, C., Swathi, V., Priyanka, C., Anjana, D. T., Subba, R. B. V., & Janaki, R. M., et al. (2016). Novel SAHA analogues inhibit HDACs, induce apoptosis and modulate the expression of microRNAs in hepatocellular carcinoma. Apoptosis, 21, 1249\u20131264.","journal-title":"Apoptosis"},{"key":"974_CR30","doi-asserted-by":"crossref","first-page":"77254","DOI":"10.18632\/oncotarget.20460","volume":"8","author":"E Bernhart","year":"2017","unstructured":"Bernhart, E., Stuendl, N., Kaltenegger, H., Windpassinger, C., Donohue, N., & Leithner, A., et al. (2017). Histone deacetylase inhibitors vorinostat and panobinostat induce G1 cell cycle arrest and apoptosis in multidrug resistant sarcoma cell lines. Oncotarget, 8, 77254\u201377267.","journal-title":"Oncotarget"},{"key":"974_CR31","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","volume":"64","author":"YA Lee","year":"2015","unstructured":"Lee, Y. A., Wallace, M. C., & Friedman, S. L. (2015). Pathobiology of liver fibrosis: a translational success story. Gut, 64, 830\u2013841.","journal-title":"Gut"},{"key":"974_CR32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","volume":"25","author":"UE Lee","year":"2011","unstructured":"Lee, U. E., & Friedman, S. L. (2011). Mechanisms of hepatic fibrogenesis. Best Practice & Research Clinical Gastroenterology, 25, 195\u2013206.","journal-title":"Best Practice & Research Clinical Gastroenterology"},{"key":"974_CR33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1126\/scitranslmed.3004700","volume":"5","author":"SL Friedman","year":"2013","unstructured":"Friedman, S. L., Sheppard, D., Duffield, J. S., & Violette, S. (2013). Therapy for fibrotic diseases: nearing the starting line. Science Translational Medicine, 5, 167.","journal-title":"Science Translational Medicine"},{"key":"974_CR34","doi-asserted-by":"publisher","first-page":"e1362","DOI":"10.7717\/peerj.1362","volume":"3","author":"W Wang","year":"2015","unstructured":"Wang, W., Yan, M., Ji, Q., Lu, J., Ji, Y., & Ji, J. (2015). Suberoylanilide hydroxamic acid suppresses hepatic stellate cells activation by HMGB1 dependent reduction of NF-\u03baB1. Peer Journal, 3, e1362 https:\/\/doi.org\/10.7717\/peerj.1362.","journal-title":"Peer Journal"},{"key":"974_CR35","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.21037\/jtd.2016.08.08","volume":"8","author":"SS Rao","year":"2016","unstructured":"Rao, S. S., Zhang, X. Y., Shi, M. J., Xiao, Y., Zhang, Y. Y., & Wang, Y. Y., et al. (2016). Suberoylanilide hydroxamic acid attenuates paraquat-induced pulmonary fibrosis by preventing Smad7 from deacetylation in rats. Journal of Thoracic Disease, 8, 2485\u20132494.","journal-title":"Journal of Thoracic Disease"},{"key":"974_CR36","doi-asserted-by":"crossref","first-page":"19605","DOI":"10.3390\/ijms141019605","volume":"14","author":"X Zhang","year":"2013","unstructured":"Zhang, X., Liu, H., Hock, T., Thannickal, V. J., & Sanders, Y. Y. (2013). Histone deacetylase inhibition downregulates collagen 3A1 in fibrotic lung fibroblasts. International Journal of Molecular Science, 14, 19605\u201319617.","journal-title":"International Journal of Molecular Science"},{"key":"974_CR37","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.hbpd.2018.09.013","volume":"17","author":"Y Wang","year":"2018","unstructured":"Wang, Y., Zhao, L., Jiao, F. Z., Zhang, W. B., Chen, Q., & Gong, Z. J. (2018). Histone deacetylase inhibitor suberoylanilide hydroxamic acid alleviates liver fibrosis by suppressing the transforming growth factor-\u03b21 signal pathway. Hepatobiliary & Pancreatic Disease International, 17, 423\u2013429.","journal-title":"Hepatobiliary & Pancreatic Disease International"},{"key":"974_CR38","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.3748\/wjg.v23.i26.4661","volume":"23","author":"S Munker","year":"2017","unstructured":"Munker, S., Wu, Y. L., Ding, H. G., Liebe, R., & Weng, H. L. (2017). Can a fibrotic liver afford epithelial-mesenchymal transition? World Journal of Gastroenterology, 23, 4661\u20134668.","journal-title":"World Journal of Gastroenterology"},{"key":"974_CR39","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/hep.23196","volume":"50","author":"SS Choi","year":"2009","unstructured":"Choi, S. S., & Diehl, A. M. (2009). Epithelial-to-mesenchymal transitions in the liver. Hepatology, 50, 2007\u20132013.","journal-title":"Hepatology"},{"key":"974_CR40","doi-asserted-by":"crossref","first-page":"7443","DOI":"10.1038\/sj.onc.1209091","volume":"24","author":"L Larue","year":"2005","unstructured":"Larue, L., & Bellacosa, A. (2005). Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3\u2019 kinase\/AKT pathways. Oncogene, 24, 7443\u20137454.","journal-title":"Oncogene"},{"key":"974_CR41","first-page":"737","volume":"51","author":"RG Wells","year":"2010","unstructured":"Wells, R. G. (2010). The epithelial-to-mesenchymal transition in liver fibrosis: here today, gone tomorrow? Hepatology, 51, 737\u2013740.","journal-title":"Hepatology"},{"key":"974_CR42","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jhep.2011.02.001","volume":"55","author":"M Pinzani","year":"2011","unstructured":"Pinzani, M. (2011). Epithelial-mesenchymal transition in chronic liver disease: fibrogenesis or escape from death? Journal of Hepatology, 55, 459\u2013465.","journal-title":"Journal of Hepatology"},{"key":"974_CR43","doi-asserted-by":"publisher","unstructured":"Park, J. H., Park, B. & Park, K. K. (2017). Suppression of hepatic epithelial-to-mesenchymal transition by melittin via blocking of TGF\u03b2\/Smad and MAPK-JNK signaling pathways. Toxins (Basel), https:\/\/doi.org\/10.3390\/toxins9040138.","DOI":"10.3390\/toxins9040138"},{"key":"974_CR44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1681\/ASN.2005111187","volume":"18","author":"M Yoshikawa","year":"2007","unstructured":"Yoshikawa, M., Hishikawa, K., Marumo, T., & Fujita, T. (2007). Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells. Journal of The American Society of Nephrology, 18, 58\u201365.","journal-title":"Journal of The American Society of Nephrology"},{"key":"974_CR45","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1111\/jcmm.12919","volume":"20","author":"SY Choi","year":"2016","unstructured":"Choi, S. Y., Kee, H. J., Kurz, T., Hansen, F. K., Ryu, Y., & Kim, G. R., et al. (2016). Class I HDACs specifically regulate E-cadherin expression in human renal epithelial cells. Journal of Cellular and Molecular Medicine, 20, 2289\u20132298.","journal-title":"Journal of Cellular and Molecular Medicine"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-021-00974-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-021-00974-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-021-00974-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T17:17:19Z","timestamp":1697995039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-021-00974-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["974"],"URL":"https:\/\/doi.org\/10.1007\/s12013-021-00974-1","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,10]]},"assertion":[{"value":"23 February 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics committee approval is not needed since it is a cell culture study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics committee approval"}},{"value":"No informed consent is needed since it is a cell culture study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}